Insulin resistance at the crossroads of metabolic syndrome: Systemic analysis using microarrays

Biotechnology Journal

Volumn 5, Issue 9, 2010, Pages 919-929

  Kim, Eunjung ^a,b  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Insulin resistance; Metabolic syndrome; Microarray analysis; Obesity; Type 2 diabetes

Indexed keywords

INSULIN RESISTANCE; METABOLIC SYNDROMES; MICROARRAY ANALYSIS; OBESITY; TYPE-2 DIABETES;

ACIDS; ANIMALS; BIOCHEMISTRY; FATTY ACIDS; GENE EXPRESSION; HISTOLOGY; LIVER; METABOLISM; MICROARRAYS; NUTRITION;

INSULIN;

FATTY ACID; INSULIN;

ADIPOCYTE; CELL CULTURE; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GLUCONEOGENESIS; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; NONHUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FATTY LIVER; GENE EXPRESSION; GLUCONEOGENESIS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MICE; MICROARRAY ANALYSIS; MUSCLES; OBESITY;

ANIMALIA;

EID: 77956690343     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000048     Document Type: Review

References (77)

1. Zimmet, P., Alberti, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787. (Pubitemid 34000780)
2. Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., et al., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295, 1549-1555.
3. Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H. et al., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289, 76-79.
4. Reaven, G. M., The insulin resistance syndrome: Definition and dietary approaches to treatment. Annu. Rev. Nutr. 2005, 25, 391-406. (Pubitemid 41209007)
5. Alberti, K. G., Lipids and diabetes: A fatal combination? Diabet. Med. 1998, 15, 359.
6. Hamilton, M. T., Hamilton, D. G., Zderic, T. W., Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56, 2655-2667.
7. Kahn, B. B., Flier, J. S., Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-481.
8. Nyholm, B., Mengel, A., Nielsen, S., Skjaerbaek, C., et al., Insulin resistance in relatives of NIDDM patients: The role of physical fitness and muscle metabolism. Diabetologia 1996, 39, 813-822. (Pubitemid 26228111)
9. Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann. Intern. Med. 1990, 113, 909-915.
10. Shulman, G. I., Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106, 171-176.
11. Kadowaki, T., Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 2000, 106, 459-465. (Pubitemid 30666378)
12. Utzschneider, K. M., Van de Lagemaat, A., Faulenbach, M. V., Goedecke, J. H. et al., Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes. Obesity 2010, in press. DOI:10.1038/oby.2010.77
13. Schenk, S., Saberi, M., Olefsky, J. M., Insulin sensitivity: Modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118, 2992-3002.
14. Saltiel, A. R., Kahn, C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806. (Pubitemid 34000783)
15. Patti, M. E., Kahn, C. R., The insulin receptor - A critical link in glucose homeostasis and insulin action. J. Basic Clin. Physiol. Pharmacol. 1998, 9, 89-109.
16. Pessin, J. E., Saltiel, A. R., Signaling pathways in insulin action: Molecular targets of insulin resistance. J. Clin. Invest. 2000, 106, 165-169.
17. Shepherd, P. R., Nave, B. T., Siddle, K., Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: Evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 1995, 305, 25-28.
18. Lietzke, S. E., Bose, S., Cronin, T., Klarlund, J. et al., Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol. Cell 2000, 6, 385-394.
19. Peterson, R. T., Schreiber, S. L., Kinase phosphorylation: Keeping it all in the family. Curr. Biol. 1999, 9, R521-524.
20. Mackay, D. J., Hall, A., Rho GTPases. J. Biol. Chem. 1998, 273, 20685-20688.
21. Ziegler, S. F., Bird, T. A., Schneringer, J. A., Schooley, K. A., Baum, P. R., Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 1993, 8, 663-670.
22. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B. et al., Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 1997, 7, 261-269. (Pubitemid 27176852)
23. Ferrannini, E., Galvan, A. Q., Gastaldelli, A., Camastra, S. et al., Insulin: New roles for an ancient hormone. Eur. J. Clin. Invest. 1999, 29, 842-852. (Pubitemid 29479102)
24. Chagnon, Y. C., Rankinen, T., Snyder, E. E., Weisnagel, S. J. et al., The human obesity gene map: The 2002 update. Obes. Res. 2003, 11, 313-367.
25. Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J. et al., The human obesity gene map: The 2005 update. Obesity 2006, 14, 529-644.
26. Chagnon, Y. C., Perusse, L., Lamothe, M., Chagnon, M. et al., Suggestive linkages between markers on human 1p32-p22 and body fat and insulin levels in the Quebec Family Study. Obes. Res. 1997, 5, 115-121.
27. Duggirala, R., Blangero, J., Almasy, L., Arya, R. et al., A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am. J. Hum. Genet. 2001, 68, 1149-1164. (Pubitemid 32424414)
28. Mitchell, B. D., Cole, S. A., Hsueh, W. C., Comuzzie, A. G. et al., Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes 2000, 49, 513-516.
29. Pratley, R. E., Thompson, D. B., Prochazka, M., Baier, L. et al., An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J. Clin. Invest. 1998, 101, 1757-1764. (Pubitemid 28198506)
30. MacLaren, R., Cui, W., Simard, S., Cianflone, K., Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J. Lipid Res. 2008, 49, 308-323. (Pubitemid 351213615)
31. Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R. et al., Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 1993, 329, 1988-1992. (Pubitemid 24015042)
32. Knowler, W. C., Bennett, P. H., Hamman, R. F., Miller, M., Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am. J. Epidemiol. 1978, 108, 497-505. (Pubitemid 9147733)
33. Bennett, P. H., Type 2 diabetes among the Pima Indians of Arizona: An epidemic attributable to environmental change? Nutr. Rev. 1999, 57, S51-54.
34. Lillioja, S., Bogardus, C., Obesity and insulin resistance: Lessons learned from the Pima Indians. Diabetes Metab. Rev. 1988, 4, 517-540.
35. Kahn, C. R., Vicent, D., Doria, A., Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu. Rev. Med. 1996, 47, 509-531. (Pubitemid 26138908)
36. Moller, D. E., Bjorbaek, C., Vidal-Puig, A., Candidate genes for insulin resistance. Diabetes Care 1996, 19, 396-400.
37. Kovacs, P., Yang, X., Permana, P. A., Bogardus, C., Baier, L. J., Polymorphisms in the oxygen-regulated protein 150 gene (ORP150) are associated with insulin resistance in Pima Indians. Diabetes 2002, 51, 1618-1621. (Pubitemid 34826633)
38. Yang, X., Pratley, R. E., Tokraks, S., Bogardus, C., Permana, P. A., Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia 2002, 45, 1584-1593. (Pubitemid 35352053)
39. Yang, X., Jansson, P. A., Nagaev, I., Jack, M. M. et al., Evidence of impaired adipogenesis in insulin resistance. Biochem. Biophys. Res. Commun. 2004, 317, 1045-1051. (Pubitemid 38496415)
40. Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., Pratley, R. E., Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43, 1498-1506. (Pubitemid 32734855)
41. Danforth, E., Jr., Failure of adipocyte differentiation causes type II diabetes mellitus? Nat. Genet. 2000, 26, 13.
42. Sreekumar, R., Halvatsiotis, P., Schimke, J. C., Nair, K. S., Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002, 51, 1913-1920. (Pubitemid 34564306)
43. Frystyk, J., Skjaerbaek, C., Vestbo, E., Fisker, S., Orskov, H., Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes. Diabetes Metab. Res. Rev. 1999, 15, 314-322. (Pubitemid 29535090)
44. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K. et al., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100, 8466-8471.
45. Nguyen, L. L., Kriketos, A. D., Hancock, D. P., Caterson, I. D., Denyer, G. S., Insulin resistance does not influence gene expression in skeletal muscle. J. Biochem. Mol. Biol. 2006, 39, 457-463. (Pubitemid 44371877)
46. Ortlepp, J. R., Kluge, R., Giesen, K., Plum, L. et al., A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. Eur. J. Clin. Invest. 2000, 30, 195-202.
47. Rudorff, K. H., Huchzermeyer, H., Windeck, R., Staib, W., [The influence of insulin on the alanine gluconeogenesis in isolated perfused livers of New Zealand obese mice]. Eur. J. Biochem. 1970, 16, 481-486.
48. Subrahmanyam, K., Metabolism in the New Zealand strain of obese mice. Biochem. J. 1960, 76, 548-556.
49. Veroni, M. C., Proietto, J., Larkins, R. G., Evolution of insulin resistance in New Zealand obese mice. Diabetes 1991, 40, 1480-1487.
50. Becker, W., Kluge, R., Kantner, T., Linnartz, K. et al., Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycemia: Evidence for a combined transcriptional dysregulation of gluconeogenesis and fatty acid synthesis. J. Mol. Endocrinol. 2004, 32, 195-208.
51. Muurling, M., Mensink, R. P., Pijl, H., Romijn, J. A. et al., A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-alpha protein concentration in ApoE-3*Leiden mice. J. Nutr. 2003, 133, 3350-3355. (Pubitemid 37409458)
52. Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J. et al., Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1706-1721.
53. van den Maagdenberg, A. M., Hofker, M. H., Krimpenfort, P. J., de Bruijn, I. et al., Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 1993, 268, 10540-10545.
54. Mahley, R. W., Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988, 240, 622-630.
55. Coort, S. L., van Iersel, M. P., van Erk, M., Kooistra, T. et al., Bioinformatics for the NuGO proof of principle study: Analysis of gene expression in muscle of ApoE3*Leiden mice on a high-fat diet using PathVisio. Genes Nutr. 2008, 3, 185-191.
56. Kleemann, R., van Erk, M., Verschuren, L., van den Hoek, A. M. et al., Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PloS One, 5, e8817.
57. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
58. Herder, C., Kolb, H., Koenig, W., Haastert, B. et al., Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: Results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 2006, 29, 368-371. (Pubitemid 44106520)
59. Verschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J. et al., MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ. Res. 2009, 105, 99-107.
60. Kanda, H., Tateya, S., Tamori, Y., Kotani, K. et al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116, 1494-1505.
61. Li, G., Liu, X., Zhu, H., Huang, L. et al., Insulin resistance in insulin-resistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism. Comp. Med. 2009, 59, 449-458.
62. Xiang, C. C., Wu, Y. J., Ma, L., Ding, L. et al., Characterisation of insulin-resistant phenotype of cultured rat primary adipose cells. Diabetologia 2007, 50, 1070-1079. (Pubitemid 46559262)
63. Shimano, H., Shimomura, I., Hammer, R. E., Herz, J. et al., Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 1997, 100, 2115-2124.
64. Gerrits, P. M., Olson, A. L., Pessin, J. E., Regulation of the GLUT4/muscle-fat glucose transporter mRNA in adipose tissue of insulin-deficient diabetic rats. J. Biol. Chem. 1993, 268, 640-644.
65. Ruan, H., Zarnowski, M. J., Cushman, S. W., Lodish, H. F., Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J. Biol. Chem. 2003, 278, 47585-47593. (Pubitemid 37523202)
66. Samad, F., Pandey, M., Bell, P. A., Loskutoff, D. J., Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes. Mol. Med. 2000, 6, 680-692.
67. Sartipy, P., Loskutoff, D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100, 7265-7270.
68. Hotamisligil, G. S., Murray, D. L., Choy, L. N., Spiegelman, B. M., Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 1994, 91, 4854-4858.
69. Stephens, J. M., Lee, J., Pilch, P. F., Tumor necrosis factor-alpha- induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem.1997, 272, 971-976. (Pubitemid 27034588)
70. Sartipy, P., Loskutoff, D. J., Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J. Biol. Chem.2003, 278, 52298-52306.
71. Bartel, D. P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
72. He, A., Zhu, L., Gupta, N., Chang, Y., Fang, F., Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 2007, 21, 2785-2794.
73. Ling, H. Y., Ou, H. S., Feng, S. D., Zhang, X. Y. et al., Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin. Exp. Pharmacol. Physiol. 2009, 36, e32-e39. DOI: 10.1111/j.1440-1681.2009. 05207.x
74. Wang, Z., Gerstein, M., Snyder, M., RNA-Seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57-63
75. Mardis, E. R., The impact of next-generation sequencing technology on genetics. Trends Genet. 2008, 24, 133-141
76. Permana, P. A., Del Parigi, A., Tataranni, P. A., Microarray gene expression profiling in obesity and insulin resistance. Nutrition 2004, 20, 134-138. (Pubitemid 38091592)
77. Kim, Y., Park, T., DNA microarrays to define and search for genes associated with obesity. Biotechnol. J. 5, 99-112.